Cramer Buy Apr 2026

: There is a documented increase in short-selling activity immediately following his buy recommendations as professional investors exploit the temporary overpricing. Recent "Buy" Recommendations (April 2026)

As of late April 2026, Cramer has shifted his focus toward healthcare and "legacy" companies effectively deploying AI. cramer buy

: Identified as an undervalued player shifting into high-growth services. : There is a documented increase in short-selling

: He remains bullish but currently advises waiting for a pullback. cramer buy